medline.ch Onkologie Respirationstrakt

	Identification of plasma SAA2 as a candidate biomarker for the detection and surveillance of non-small cell lung cancer. Neoplasma Zhang FF, Han B, Xu RH, Zhu QQ, Wu QQ, Wei HM, Cui ZL, Zhang SL, Meng MJ. PMID: 34648299 [PubMed - as supplied by publisher]
	Safety of immune checkpoint inhibitors in non-small-cell lung cancer patients with idiopathic interstitial pneumonia: a matched case-control study. Cancer Chemother Pharmacol Ichimura T, Hinata M, Ichikura D, Suzuki S. PMID: 34648059 [PubMed - as supplied by publisher]
	Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial. JAMA Oncol Zhou C, Ramalingam SS, Kim TM, Kim SW, Yang JC, Riely GJ, Mekhail T, Nguyen D, Garcia Campelo MR, Felip E, Vincent S, Jin S, Griffin C, Bunn V, Lin J, Lin HM, Mehta M, Jänne PA. PMID: 34647988 [PubMed - as supplied by publisher]
	The Clinical Value of Pulmonary Rehabilitation in Reducing Postoperative Complications and Mortality of Lung Cancer Resection: A Systematic Review and Meta-Analysis. Front Surg Mao X, Ni Y, Niu Y, Jiang L. PMID: 34646857 [PubMed]
	Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses. Ther Adv Med Oncol Gristina V, Galvano A, Castellana L, Insalaco L, Cusenza S, Graceffa G, Iacono F, Barraco N, Castiglia M, Perez A, Rizzo S, Russo A, Bazan V. PMID: 34646363 [PubMed]
	The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials. World J Surg Oncol Liu Q, Zhang Y, Liu M, Xu R, Yi F, Wei Y, Zhu S, Zhang W. PMID: 34645484 [PubMed - in process]
	The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer. Patient Bever A, Manthorne J, Rahim T, Moumin L, Szabo SM. PMID: 34643935 [PubMed - as supplied by publisher]
	Comparison of operative and postoperative characteristics and outcomes between thoracoscopic segmentectomy and lobectomy for non-small-cell lung cancer: a propensity score matching study from the Italian VATS Group Registry. Eur J Cardiothorac Surg Dell'Amore A, Lomangino I, Cannone G, Terzi S, Pangoni A, Lorenzoni G, Nicotra S, Schiavon M, Zuin A, Gregori D, Crisci R, Curcio C, Rea F, Italian VATS Group.. PMID: 34643695 [PubMed - as supplied by publisher]
	Pembrolizumab provides long-term survival benefits in advanced non-small cell lung cancer: The 5-year outcomes of the KEYNOTE-024 trial. Thorac Cancer Li F, Dong X. PMID: 34643064 [PubMed - as supplied by publisher]
	Deep Mining Generation of Lung Cancer Malignancy Models from Chest X-ray Images. Sensors (Basel) Horry M, Chakraborty S, Pradhan B, Paul M, Gomes D, Ul-Haq A, Alamri A. PMID: 34640976 [PubMed - indexed for MEDLINE]
	PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis. J Clin Med García Campelo MR, Arriola E, Campos Balea B, López-Brea M, Fuentes-Pradera J, de Castro Carpeno J, Aguado C, Pérez Parente D, de Oro Pulido F, Ruiz-Gracia P, Rodríguez-Abreu D. PMID: 34640601 [PubMed]
	First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis. J Clin Med Wu KL, Chen HL, Tsai YM, Lee TH, Chang HM, Tsai YC, Chuang CH, Chang YC, Tu YK, Yang CJ, Hung JY, Chong IW. PMID: 34640394 [PubMed]
	Environmental/Occupational Exposure to Radon and Non-Pulmonary Neoplasm Risk: A Review of Epidemiologic Evidence. Int J Environ Res Public Health Mozzoni P, Pinelli S, Corradi M, Ranzieri S, Cavallo D, Poli D. PMID: 34639764 [PubMed - in process]
	Excess Body Weight and Long-Term Incidence of Lung and Colon Cancer in Men; Follow-Up Study of 43 Years. Int J Environ Res Public Health Gepner Y, Lev-Ari S, Goldbourt U. PMID: 34639717 [PubMed - in process]
	Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment. Int J Mol Sci Yang Y, Li N, Wang TM, Di L. PMID: 34639167 [PubMed - in process]
	RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases. Int J Mol Sci Teng PC, Liang Y, Yarmishyn AA, Hsiao YJ, Lin TY, Lin TW, Teng YC, Yang YP, Wang ML, Chien CS, Luo YH, Chen YM, Hsu PK, Chiou SH, Chien Y. PMID: 34638933 [PubMed - in process]
	Gut Microbiota in Lung Cancer: Where Do We Stand? Int J Mol Sci Georgiou K, Marinov B, Farooqi AA, Gazouli M. PMID: 34638770 [PubMed - in process]
	Effect of Exercise Training on Quality of Life after Colorectal and Lung Cancer Surgery: A Meta-Analysis. Cancers (Basel) Machado P, Pimenta S, Oliveiros B, Ferreira JP, Martins RA, Cruz J. PMID: 34638459 [PubMed]
	Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring. Cancers (Basel) Reita D, Pabst L, Pencreach E, Guérin E, Dano L, Rimelen V, Voegeli AC, Vallat L, Mascaux C, Beau-Faller M. PMID: 34638411 [PubMed]
	Lung Cancer Surgery after Treatment with Anti-PD1/PD-L1 Immunotherapy for Non-Small-Cell Lung Cancer: A Case-Cohort Study. Cancers (Basel) El Husseini K, Piton N, De Marchi M, Grégoire A, Vion R, Blavier P, Thiberville L, Baste JM, Guisier F. PMID: 34638399 [PubMed]

Artikel 1 - 20 / 119164

Seite 1 von 5959

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung